Panacea Biotec Pharma Limited Glucosamine Export Data — India (DGFT 2022–2026)

Name: Panacea Biotec Pharma Limited Glucosamine Export Records India — #1 Exporter, 41 Shipments, $1.8M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-04-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Glucosamine

India Pharmaceutical Trade Intelligence

$13.3M118 Suppliers65 CountriesHS 30049099

ExportsIndia → NIGERIA17.0%India → RUSSIA16.3%

ImportsUNITED STATES → India$28.2K ITALY → India$1.1K

#1 Supplier: PANACEA BIOTEC #1 Buyer: FIDSON HEALTHCARE

Panacea Biotec Pharma Limited — Glucosamine Exporter #1 | $1.8M Trade Value | TransData Nexus | TransData Nexus

Panacea Biotec Pharma Limited — Glucosamine Exporter Profile

Indian Pharmaceutical Exporter · #1 for Glucosamine · $1.8M export value · DGFT Verified

Panacea Biotec Pharma Limited is the #1 Indian exporter of Glucosamine with $1.8M in export value and 41 verified shipments. Panacea Biotec Pharma Limited holds a 13.9% market share in Glucosamine exports across 1 countries. The company exports 13 pharmaceutical products worth $23.9M across 9 therapeutic categories.

Panacea Biotec Pharma Limited — Glucosamine Export Profile: Buyers & Destinations

Panacea Biotec Pharma Limited Glucosamine export treemap — buyers and destination countries | TransData Nexus

Where Does India Export Glucosamine?

Country	Value	Shipments	Share
RUSSIA	$2.2M	64	20.0%
NIGERIA	$1.6M	33	15.3%
SINGAPORE	$1.4M	30	12.7%
FRANCE	$1.3M	54	12.0%

Who Are the Top Buyers of Glucosamine from India?

Buyer	Country	Value	Orders
PANBIO PHARM LLC	RUSSIA	$1.5M	35
FIDSON HEALTHCARE PLC	NIGERIA	$1.2M	24
MOVI HEALTH LLC	POLAND	$868.3K	24
PHARMAZEN MEDICALS PTE LTD.,	SINGAPORE	$800.0K	16
PLANET PHARMA	FRANCE	$724.8K	23
ORGANOSYN LIMITED LLC	UKRAINE	$419.3K	14
PHARMAZEN MEDICALS PTE LIMITED	SINGAPORE	$278.3K	6
SUED & FARGESA SRL	DOMINICAN REPUBLIC	$221.1K	6
CLARION MEDICALS LIMITED	NIGERIA	$200.0K	4
AL HAMRIA DRUG STORE LLC,	UNITED ARAB EMIRATES	$150.0K	3

India's Glucosamine is purchased by 197 buyers worldwide. The top buyer is PANBIO PHARM LLC (RUSSIA), followed by FIDSON HEALTHCARE PLC and MOVI HEALTH LLC.

How Does Panacea Biotec Pharma Limited Compare to Nearest Glucosamine Exporters?

Exporters ranked immediately above and below #1 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
1	PANACEA BIOTEC PHARMA LIMITED ★	$1.8M	41	1	$45.1K
3	MEDREICH LIMITED	$1.4M	27	2	$50.0K
2	MEDINOMICS HEALTH CARE PRIVATE LIMITED	$1.2M	24	1	$50.0K

Panacea Biotec Pharma Limited ranks #1 among 118 Indian Glucosamine exporters. Average shipment value of $45.1K compared to the market average of $84.0K. The closest competitors by value are MEDREICH LIMITED and MEDINOMICS HEALTH CARE PRIVATE LIMITED.

Which Indian Ports Ship Glucosamine Exports?

Port	Shipments	% Share
SAHAR AIR	57	8.7%
CHENNAI AIR CARGO ACC (INMAA4)	45	6.8%
CHENNAI AIR	41	6.2%
CHENNAI SEA (INMAA1)	39	5.9%
DELHI AIR	36	5.5%
MUNDRA SEA	34	5.2%
SAHAR AIR CARGO ACC (INBOM4)	29	4.4%
NHAVA SHEVA SEA (INNSA1)	28	4.3%

Geopolitical & Trade Policy Impact on Panacea Biotec Pharma Limited's Glucosamine Exports

The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like Panacea Biotec. The Israel-Iran conflict has led to disruptions in Red Sea shipping routes, causing increased freight charges and potential delays. These maritime disruptions are particularly concerning for time-sensitive pharmaceutical shipments, as extended transit times and congestion elevate the risk of cold-chain failures for vaccines and biologics. (pharmaceuticalcommerce.com)

In the United States, recent tariff implementations have introduced uncertainties for Indian exporters. While health products have been exempt from U.S. tariffs, there is growing concern that this exemption may not be permanent. The potential imposition of tariffs on pharmaceutical imports could impact Panacea Biotec's profitability, given the company's significant export volume to the U.S. market. (lemonde.fr)

Conversely, the U.S.-China trade tensions have opened avenues for Indian pharmaceutical companies to capture market share previously held by Chinese manufacturers. This shift presents an opportunity for Panacea Biotec to expand its footprint in the U.S. market, provided it can navigate the evolving regulatory and trade environment effectively.

In the European Union, compliance with the Falsified Medicines Directive (FMD) remains a critical requirement for exporters. The recent GMP non-compliance issue at Panacea Biotec's Baddi facility underscores the importance of adhering to stringent EU regulations. Addressing these compliance challenges promptly is essential to maintain and grow the company's presence in European markets.

Panacea Biotec Pharma Limited — Regulatory Compliance & Quality Standards

The global pharmaceutical industry is witnessing heightened regulatory scrutiny, with agencies like the U.S. FDA and the European Medicines Agency (EMA) enforcing stringent quality standards. For Indian exporters, maintaining compliance with these standards is paramount to ensure uninterrupted market access.

Panacea Biotec's recent GMP non-compliance at its Baddi facility highlights the critical need for robust quality management systems. The company has committed to implementing comprehensive corrective and preventive actions and plans to request a re-inspection to reinstate its GMP certificates. (prysm.fi) Proactive measures in quality assurance will be vital for Panacea Biotec to rebuild trust with regulatory bodies and international clients.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Glucosamine shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Panacea Biotec Pharma Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 65+ countries, 197+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Glucosamine

Glucosamine

Panacea Biotec Pharma Limited — Glucosamine Exporter Profile

Panacea Biotec Pharma Limited — Glucosamine Export Profile: Buyers & Destinations

Where Does India Export Glucosamine?

Who Are the Top Buyers of Glucosamine from India?

What Is India's Total Glucosamine Export Value and How Much Does Panacea Biotec Pharma Limited Contribute?

What Is the Average Shipment Value for Panacea Biotec Pharma Limited's Glucosamine Exports?

How Does Panacea Biotec Pharma Limited Compare to Other Indian Glucosamine Exporters?

Regulatory Requirements: Exporting Glucosamine to Key Markets

Nigeria — NAFDAC

How Does Panacea Biotec Pharma Limited Compare to Nearest Glucosamine Exporters?

Which Indian Ports Ship Glucosamine Exports?

What Other Nutritional Supplements Products Does Panacea Biotec Pharma Limited Export?

Geopolitical & Trade Policy Impact on Panacea Biotec Pharma Limited's Glucosamine Exports

Panacea Biotec Pharma Limited — Regulatory Compliance & Quality Standards

About Panacea Biotec Pharma Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Glucosamine Export Data from Panacea Biotec Pharma Limited

Glucosamine Stats

Company Overview

Top Products by Panacea Biotec Pharma Limited

Related Analysis

Need Detailed Export Data?

Data Source